Klingenstein Fields & CO LP Zoetis Inc. Transaction History
Klingenstein Fields & CO LP
- $2.49 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding ZTS
# of Institutions
2,124Shares Held
430MCall Options Held
1.47MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA41.9MShares$6.05 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$5.32 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.7MShares$2.85 Billion0.12% of portfolio
-
Morgan Stanley New York, NY17.7MShares$2.56 Billion0.19% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$2.29 Billion2.21% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $67.6B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...